Pendle, a DeFi protocol, enables investors to lock in fixed rates on-chain by splitting yield-bearing assets into tradable Principal Tokens (PT) and Yield Tokens (YT). This approach turns volatile future yields into predictable cash flows, appealing to builders, treasuries, and crypto funds seeking income certainty. With matured liquidity and tooling, Pendle supports various assets including staking tokens and stablecoins, allowing users to hedge risks or speculate on yields. Despite risks like smart contract vulnerabilities and liquidity issues near maturity, fixed-rate DeFi is gaining traction as a core crypto investment tool, providing an alternative to variable yields and centralized finance products.
Industrial Alliance Securities lowered Abeona Therapeutics' price target from $20 to $15 following a 14% stock drop after the company reported Q2 revenues of $11.4 million, missing analyst expectations. The company faces operational challenges with i...
Inovio Pharmaceuticals is progressing its DNA medicine pipeline with its lead candidate INO-3107 for Recurrent Respiratory Papillomatosis under FDA accelerated review, targeting a decision by October 30, 2026. The company raised $18.3 million in fund...
Morin Brit, a director at Life360, sold 15,582 shares of the company, generating $1 million from the transaction. This sale may indicate a personal financial decision or portfolio adjustment by the director. Investors might watch for any further insi...
AbCellera Biologics announced positive Phase 2 trial results for its experimental menopause drug ABCL635, which significantly reduced hot flash frequency by 83%. The stock surged 33.19% to a 52-week high of $11.32, boosting the company's market cap t...
TOMI Environmental Solutions reported a 118% year-over-year revenue increase to $2.25 million, surpassing analyst estimates of $1.84 million. The company also beat EPS expectations with a loss of $0.05 per share, better than the anticipated loss of $...
